FDA Inspection 1244033 — GlaxoSmithKline Manufacturing S.P.A.
The FDA completed an inspection of GlaxoSmithKline Manufacturing S.P.A. on Oct 26, 2023 in Torrile. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Oct 26, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Torrile (Italy)
Additional details
Mutual Recognition Agreement (MRA)